News
Presentation of The NGAL Test data at the 30th International Symposium on Intensive Care and Emergency Medicine (ISICEM)
February 22 2010
TSIS 2010, March 9-13, Munich, Germany
February 18 2010
ToxExpo, March 7-11, Salt Lake City, Utah
February 16 2010
CRITICARE 2010, February 10-14, Hyderabad, India
January 25 2010
SCCM Annual Congress, January 9-13, Miami Beach, Florida
January 07 2010
BioPorto Diagnostics and ALPCO Diagnostics enter into partnership
December 02 2009
Product launch: Dog NGAL ELISA Kit (KIT 043)
November 16 2009
MEDICA, November 18-21, Düsseldorf, Germany
November 09 2009
BioPorto introduces The NGAL Test at the ASN Renal Week 2009, October 27 – November 1, San Diego
October 16 2009
Breakthrough test can prevent fatal kidney failure
September 21 2009
BioPorto introduces The NGAL Test at the ASN Renal Week 2009, October 27 – November 1, San Diego
October 16 2009 by Ana Belén Enfedaque Buisán
The ASN Renal Week is the world’s most significant nephrology meeting devoted to the latest advances in nephrology research, clinical care and education. More than 13,000 doctors, scientists and other healthcare professionals from all over the world are expected to take part in the congress.
Over the past few years NGAL has been established as a promising new biomarker for diagnosing acute kidney injury and therefore, one could not think of a better venue for BioBorto to introduce its latest addition to the NGAL portfolio; The NGAL Test*. The test is designed for routine diagnostics on open high throughput apparatus that already exists in hospitals. This secures that the test will be readily available to doctors world wide after launch scheduled early 2011.
The overall theme for this year’s meeting includes major areas in basic, translational, and clinical sciences. In particular, four featured topics will be highlighted: Epithelial Transport and Cell Biology; Renal Immunology and Transplantation; New Insights into Glomerular Structure and Function; and Kidney Development and Stem Cells.
The American Society of Nephrology (ASN) is the world’s largest organization dedicated to the study and practice of nephrology. This October, the 42nd Annual Meeting of the American Society of Nephrology will be held in San Diego.
The NGAL product line from BioPorto Diagnostics includes ELISA kits for research and in vitro diagnostics as well as a wide selection of reagents for use in animal models which include antibodies against human, mouse, rat, monkey, dog and pig NGAL.
For more information or setting up an appointment, please meet BioPorto Diagnostics personnel at booth nr. 315:
Jakob Ohm Eriksen, Pharma Diagnostics Product Manager, joe@bioporto.com
Klaus Boberg Pedersen, Human Diagnostics Product Manager, kbp@bioporto.com
Ana Belén Enfedaque Buisán, Marketing Coordinator, aeb@bioporto.com
*Technical data will be available soon.
For further information on ASN Renal Week: www.asn-online.org
